Novartis AG Diluted Earnings Loss Per Share From Discontinued Operations
Novartis AG (NVSEF) reported Diluted Earnings Loss Per Share From Discontinued Operations of $3.00 per share for the 12-month period ending 2023-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations · last filed 2026-02-04
- Novartis AG diluted earnings loss per share from discontinued operations for the quarter ending 2023-06-30 was $0.02.
- Novartis AG diluted earnings loss per share from discontinued operations for the quarter ending 2019-06-30 was $2.01, a 9950.00% increase year-over-year.
- Novartis AG diluted earnings loss per share from discontinued operations for the quarter ending 2018-06-30 was $0.02.
| Period end | Diluted Earnings Loss Per Share From Discontinued Operations 3 month | Diluted Earnings Loss Per Share From Discontinued Operations 6 month | Diluted Earnings Loss Per Share From Discontinued Operations 12 month |
|---|---|---|---|
| 2023-12-31 | $3.00 20-F · filed 2026-02-04 | ||
| 2023-06-30 | $0.02 6-K · filed 2024-07-18 | $0.09 6-K · filed 2024-07-18 | |
| 2022-12-31 | $0.41 20-F · filed 2025-01-31 | ||
| 2021-12-31 | $0.49 20-F · filed 2024-01-31 | ||
| 2019-12-31 | $1.98 20-F · filed 2022-02-02 | ||
| 2019-06-30 | $2.01 6-K · filed 2020-07-21 | $1.96 6-K · filed 2020-07-21 | |
| 2018-12-31 | -$0.08 20-F · filed 2021-01-26 | ||
| 2018-06-30 | $0.02 6-K · filed 2019-07-18 | $0.04 6-K · filed 2019-07-18 | |
| 2017-12-31 | $0.08 20-F · filed 2020-01-29 | ||
| 2015-12-31 | $4.41 6-K · filed 2018-01-24 |